{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1029.127","meta":{"versionId":"21","lastUpdated":"2021-06-11T01:01:24.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Joint Commission Author"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-keyWord","valueString":"PC-06"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-06-11"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.127","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1029.127"}],"version":"20210611","name":"MaternalDrugUse","title":"Maternal Drug Use","status":"active","experimental":false,"date":"2021-06-11T01:01:24-04:00","publisher":"Joint Commission","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to group diagnoses of maternal drug use.),(Data Element Scope: This value set may use a model element related to\u00a0diagnosis.),(Inclusion Criteria: Includes concepts that identify a diagnosis of maternal drug use.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.126"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.125"]}]},"expansion":{"identifier":"urn:uuid:e65be3d3-cd80-413c-88da-2bd8ccf14b90","timestamp":"2023-12-10T20:28:50-05:00","total":33,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"103031000119101","display":"Fetal exposure to teratogenic substance (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"17231009","display":"Fetal valproate syndrome (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"205788004","display":"Fetal alcohol syndrome (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"206573003","display":"Withdrawal symptoms from therapeutic use of drugs in newborn (finding)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"20952006","display":"Neonatal effect of noxious substance transmitted via breast milk (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"254251003","display":"Fetal minoxidil syndrome (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"254253000","display":"Fetal primidone syndrome (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"363127005","display":"Fetal disorder caused by chemicals (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"38323006","display":"Fetal warfarin syndrome (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"429211000124107","display":"Fetus affected by placental transfer of anticonvulsant (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"609437000","display":"Fetal Alcohol Spectrum Disorder (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"698321001","display":"Neonatal effect of alcohol transmitted via breast milk (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"698403003","display":"Neonatal effect of anti-infective agent transmitted via breast milk (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"720822008","display":"Withdrawal symptom (finding)"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.11","display":"Newborn affected by maternal antineoplastic chemotherapy"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.12","display":"Newborn affected by maternal cytotoxic drugs"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.13","display":"Newborn affected by maternal use of anticonvulsants"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.14","display":"Newborn affected by maternal use of opiates"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.15","display":"Newborn affected by maternal use of antidepressants"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.16","display":"Newborn affected by maternal use of amphetamines"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.17","display":"Newborn affected by maternal use of sedative-hypnotics"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.18","display":"Newborn affected by other maternal medication"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.19","display":"Newborn affected by maternal use of unspecified medication"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.1A","display":"Newborn affected by maternal use of anxiolytics"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.3","display":"Newborn affected by maternal use of alcohol"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.40","display":"Newborn affected by maternal use of unspecified drugs of addiction"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.41","display":"Newborn affected by maternal use of cocaine"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.42","display":"Newborn affected by maternal use of hallucinogens"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.49","display":"Newborn affected by maternal use of other drugs of addiction"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.81","display":"Newborn affected by maternal use of cannabis"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P04.89","display":"Newborn affected by other maternal noxious substances"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P96.1","display":"Neonatal withdrawal symptoms from maternal use of drugs of addiction"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"P96.2","display":"Withdrawal symptoms from therapeutic use of drugs in newborn"}]}}